Profile of cabozantinib and its potential in the treatment of advanced medullary thyroid cancer

Medullary thyroid cancer is an uncommon malignancy for which until recently little effective treatment existed. It is often characterized by mutation and overexpression of the receptor tyrosine kinases RET (rearranged during transfection), VEGFR2 (vascular endothelial growth factor receptor 2) and M...

Descripción completa

Detalles Bibliográficos
Autores principales: Hart, Christopher D, De Boer, Richard H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540909/
https://www.ncbi.nlm.nih.gov/pubmed/23319867
http://dx.doi.org/10.2147/OTT.S27671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540909/
https://www.ncbi.nlm.nih.gov/pubmed/23319867
http://dx.doi.org/10.2147/OTT.S27671

Ejemplares similares